Skip to main content
Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
4.100
-0.230 (-5.31%)
At close: Jun 6, 2025, 4:00 PM
4.040
-0.060 (-1.46%)
After-hours: Jun 6, 2025, 6:02 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Pharmaceutical
1.41M
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Growth
-58.15%
Log In
Log In
Log In
Log In
Upgrade
License and Other
516.00K
Log In
Log In
Log In
Log In
Upgrade
License and Other Growth
-96.49%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
1.92M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-89.34%
Log In
Log In
Log In
Log In
Upgrade